Thomas Mullen
Chief Executive Officer
Replay available
Select Medical Holdings Corporation (NYSE: SEM) Q4 2025 earnings conference call, held 2026-02-20. Replay captured from the company's public earnings webcast.

Chief Executive Officer
Executive Vice President and Chief Financial Officer
Analyst, RBC Capital Markets
Analyst, Deutsche Bank
Analyst, Mizuho
Analyst, Bank of America
Analyst, UBS
Analyst, Benchmark StoneX
Good morning, and thank you for joining us today for Select Medical Holdings Corporation's earnings conference call to discuss the fourth quarter and full year 2025 results in the company's business outlook. Presenting today are the company's chief executive officer, Thomas Mullen, and the company's executive vice president and chief financial officer, Michael Malatesta. Also on the conference line is the company's senior vice president, controller, and chief accounting officer, Christopher Weigel. Manson will give you an overview of the quarter and then open the call for your questions. Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events for the future financial performance of the company, including without limitation statements regarding operating results, growth opportunities, and other statements that refer to select medical plans, expectations, strategies, intentions, and beliefs. These forward-looking statements are based on the information available to management of Select Medical today, and the company assumes no obligation to update these statements as circumstances change. At this time, I will turn the conference call over to Mr. Thomas Mullen. Thank you, operator, and good morning, everyone. Welcome to Select Medical's fourth quarter 2025 earnings call. I'd like to begin our call by taking a moment to address the Take Private proposal that was recently submitted by our executive chairman. On November 24th, we received a non-binding indication of interest to acquire all outstanding shares of Select Medical. A special committee of the board of directors is in the process of carefully reviewing and evaluating the proposal. This process is ongoing and the special committee ...